Blood test could spare thousands from unnecessary breast cancer scares
NCT ID NCT07049822
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is testing whether a simple blood test can help rule out breast cancer in women who had a suspicious mammogram. About 75% of women called back for extra testing turn out to be fine, but they still go through stressful and unnecessary procedures. The goal is to use blood biomarkers to identify low-risk women and avoid those extra mammograms and biopsies. The study will enroll 1,200 women from the Danish breast cancer screening program.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
blood-based biomarker test
What this could lead to
If successful, this could make breast cancer screening more accurate and reduce the need for additional, often unnecessary, mammograms and biopsies.
What could go wrong
This is an early-stage study focused on correlation, not a proven diagnostic test. The blood test may not be accurate enough to replace current procedures, and results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Odense University Hospital
Odense, 5000, Denmark
-
Vejle Hospital
Vejle, 7100, Denmark